Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000300688 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Initial Experience With Senhance-Assisted Laparoscopic Partial Cystectomy Using the Double Bipolar Method With 3 mm Bipolar Instruments.
Cureus
November 2024
Gastroenterological Surgery, Saitama Medical University International Medical Center, Hidaka, JPN.
The Senhance robotic system (Asensus Surgical, Durham, NC, USA) is an innovative platform for minimally invasive surgery. It enables surgeons to perform precise and cost-effective procedures using reusable instruments and has advanced features such as haptic feedback and eye-tracking camera control. Herein, we present the first application of the "double bipolar method" (DBM) in a Senhance-assisted laparoscopic partial cystectomy utilizing 3 mm Maryland bipolar instruments.
View Article and Find Full Text PDFJehovah's Witnesses: Challenges in liver disease management and in liver transplantation.
Liver Transpl
October 2024
Recanati/Miller Transplantation Institute, Mount Sinai Hospital, New York, New York, USA.
Patients of Jehovah's Witnesses faith who are in need of liver transplantation pose unique challenges. These patients should be seen at transplant centers with experience in caring for Jehovah's Witnesses to formulate careful preoperative, intraoperative, and postoperative strategies on an individualized basis with multidisciplinary input to mitigate the risk of bleeding complications and to prepare for potentially catastrophic scenarios. In-depth and individualized conversations about what constitutes acceptable bloodless transfusion strategies both for the patient and for the transplant center should begin as early as possible with an experienced coordinator or church liaison.
View Article and Find Full Text PDFShared decision-making for patients with vaccine-related concerns of blood transfusion: A single institution experience.
Transfusion
December 2024
Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Background: Some patients express concerns regarding receipt of allogeneic blood transfusions from donors potentially vaccinated against SARS-CoV-2 (COVID-19). However, limited information exists about patients' expression of these concerns or how to address them during the blood transfusion consent process. In this study, we describe our experience of working collaboratively with patients with vaccine-related transfusion concerns prior to elective surgery, summarizing treatment decisions and clinical outcomes.
View Article and Find Full Text PDFBackground: Allogeneic hematopoietic stem cell transplantation (alloHSCT) poses challenges for patients who decline blood products because of religious beliefs or other reasons. Despite potential curative prospects, many institutions refrain from offering alloHSCT to patients who decline blood products because of safety concerns associated with cytopenias.
Objectives: This review focuses on one institution's experience of conducting alloHSCT without blood components, emphasizing preparation and supportive care.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!